Your browser doesn't support javascript.
loading
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis.
Afiliação
  • Ready NE; Department of Medicine, Duke University, Durham, North Carolina, USA neal.ready@duke.edu.
  • Audigier-Valette C; Division of Pneumo-Oncology, Hôpital Sainte Musse, Toulon, Provence-Alpes-Côte d'Azur, France.
  • Goldman JW; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Felip E; Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Ciuleanu TE; Department of Oncology, Oncology Institute Prof Dr Ion Chiricuta, Cluj-Napoca, Romania.
  • Rosario García Campelo M; University of Medicine and Pharmacy Iuliu Hațieganu, Cluj-Napoca, Romania.
  • Jao K; Medical Oncology Unit, University Hospital A Coruña (XXIAC-SERGAS), A Coruña, Spain.
  • Barlesi F; Division of Medical Oncology and Hematology, Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada.
  • Bordenave S; Department of Thoracic Oncology, Aix-Marseille Université, CNRS, INSERM, CRCM, Assistance Publique-Hôpitaux de Marseille (APHM), Marseille, Provence-Alpes-Côte d'Azur, France.
  • Rijavec E; Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Urban L; Department of Thoracic and Digestive Medical Oncology, Centre Hospitalier Universitaire de Nantes, Nantes, Pays de la Loire, France.
  • Aucoin JS; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Lombardia, Italy.
  • Zannori C; Onco-pulmonology Department, Matrahaza University and Teaching Hospital, Matrahaza, Heves, Hungary.
  • Vermaelen K; Division of Medical Oncology and Hematology, Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-Centre-du-Québec, Trois-Rivières, Quebec, Canada.
  • Arén Frontera O; Department of Medical Oncology, Azienda Ospedaliera Santa Maria di Terni, Terni, Umbria, Italy.
  • Curioni Fontecedro A; Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium.
  • Sánchez-Gastaldo A; Department of Medical Oncology, Centro de Investigación Clínica Bradford Hill, Santiago, RM, Chile.
  • Juan-Vidal O; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Linardou H; Department of Oncology, University of Fribourg, Fribourg, Fribourg, Switzerland.
  • Poddubskaya E; Medical Oncology Department, Hospital Universitario "Virgen del Rocio", Seville, Spain.
  • Spigel DR; Department of Medical Oncology, Hospital Politécnico y Universitario La Fe, Valencia, Comunidad Valenciana, Spain.
  • Ahmed S; 4th Oncology Department and Comprehensive Clinical Trials Centre, Metropolitan Hospital Athens, Athens, Attike, Greece.
  • Maio M; Clinical Center VitaMed, Moscow, Russian Federation.
  • Li S; Department of Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA.
  • Chang H; Department of Medical Oncology, University Hospitals of Leicester NHS Trust, Leicester, Leicester, UK.
  • Fiore J; Department of Oncology, University of Siena and Center for Immuno-Oncology, University Hospital, Siena, Italy.
  • Acevedo A; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Paz-Ares L; Department of Translational Bioinformatics, Bristol Myers Squibb, Princeton, New Jersey, USA.
J Immunother Cancer ; 11(2)2023 02.
Article em En | MEDLINE | ID: mdl-36725084
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos